Entrada Therapeutics Inc (TRDA): Congress and insider trades
Who in Congress and inside the company traded TRDA, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Entrada Therapeutics Inc (TRDA) is a listed stock on NASDAQ.
- Insiders filed 1 open market buy worth $29.3K and 36 sells worth $11M, the latest filed 2026-09-09 (9 September 2026).
- Across 1 scored buy, Insiders averaged +13.3% against the S&P 500 (SPY) over the 90 days after disclosure, with 100% of them ahead of the index. That result is too few trades to tell.
- Data as of 2026-09-29 (29 September 2026).
Insider trades in TRDA
as of 2026-09-09| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 9 Sep 2026 | MPM BIOVENTURES 2018, L.P. | sell | 192,500 | $7.41 | $1.4M | n/a |
| 9 Sep 2026 | MPM BioVentures 2014, L.P. | sell | 192,500 | $7.41 | $1.4M | n/a |
| 9 Sep 2026 | MPM BioVentures 2014, L.P. | sell | 38,500 | $7.11 | $274K | n/a |
| 9 Sep 2026 | MPM BIOVENTURES 2018, L.P. | sell | 38,500 | $7.11 | $274K | n/a |
| 9 Sep 2026 | MPM BioVentures 2014, L.P. | sell | 28,837 | $7.13 | $206K | n/a |
| 9 Sep 2026 | MPM BIOVENTURES 2018, L.P. | sell | 28,837 | $7.13 | $206K | n/a |
| 3 Sep 2026 | MPM BIOVENTURES 2018, L.P. | sell | 32,263 | $7.17 | $231K | n/a |
| 3 Sep 2026 | MPM BioVentures 2014, L.P. | sell | 32,263 | $7.17 | $231K | n/a |
| 3 Sep 2026 | MPM BIOVENTURES 2018, L.P. | sell | 29,088 | $7.06 | $205K | n/a |
| 3 Sep 2026 | MPM BioVentures 2014, L.P. | sell | 25,131 | $7.19 | $181K | n/a |
| 3 Sep 2026 | MPM BIOVENTURES 2018, L.P. | sell | 25,131 | $7.19 | $181K | n/a |
| 3 Sep 2026 | MPM BioVentures 2014, L.P. | sell | 29,088 | $7.06 | $205K | n/a |
| 31 Aug 2026 | MPM BIOVENTURES 2018, L.P. | sell | 3,733 | $7.01 | $26.2K | n/a |
| 31 Aug 2026 | MPM BioVentures 2014, L.P. | sell | 3,733 | $7.01 | $26.2K | n/a |
| 31 Aug 2026 | MPM BioVentures 2014, L.P. | sell | 44,259 | $6.99 | $309K | n/a |
| 31 Aug 2026 | MPM BioVentures 2014, L.P. | sell | 38,922 | $7.20 | $280K | n/a |
| 31 Aug 2026 | MPM BIOVENTURES 2018, L.P. | sell | 38,922 | $7.20 | $280K | n/a |
| 31 Aug 2026 | MPM BIOVENTURES 2018, L.P. | sell | 44,259 | $6.99 | $309K | n/a |
| 26 Aug 2026 | MPM BioVentures 2014, L.P. | sell | 14,569 | $7.06 | $103K | n/a |
| 26 Aug 2026 | MPM BIOVENTURES 2018, L.P. | sell | 26,522 | $7.54 | $200K | n/a |
| 26 Aug 2026 | MPM BIOVENTURES 2018, L.P. | sell | 21,623 | $7.34 | $159K | n/a |
| 26 Aug 2026 | MPM BioVentures 2014, L.P. | sell | 21,623 | $7.34 | $159K | n/a |
| 26 Aug 2026 | MPM BioVentures 2014, L.P. | sell | 26,522 | $7.54 | $200K | n/a |
| 26 Aug 2026 | MPM BIOVENTURES 2018, L.P. | sell | 14,569 | $7.06 | $103K | n/a |
| 10 Aug 2026 | PARMAR KUSH | sell | 52,317 | $6.85 | $358K | n/a |
| 10 Aug 2026 | 5AM Ventures V, L.P. | sell | 10,494 | $7.00 | $73.5K | n/a |
| 10 Aug 2026 | PARMAR KUSH | sell | 92,444 | $7.00 | $647K | n/a |
| 10 Aug 2026 | 5AM Ventures V, L.P. | sell | 52,317 | $6.85 | $358K | n/a |
| 10 Aug 2026 | PARMAR KUSH | sell | 10,494 | $7.00 | $73.5K | n/a |
| 3 Aug 2026 | PARMAR KUSH | sell | 1,718 | $6.85 | $11.8K | n/a |
| 3 Aug 2026 | 5AM Ventures V, L.P. | sell | 114,756 | $6.93 | $795K | n/a |
| 3 Aug 2026 | 5AM Ventures V, L.P. | sell | 1,718 | $6.85 | $11.8K | n/a |
| 3 Aug 2026 | PARMAR KUSH | sell | 114,756 | $6.93 | $795K | n/a |
| 21 May 2026 | Zeiher Bernhardt G | buy | 5,000 | $5.86 | $29.3K | +13.3% |
| 4 May 2026 | Dowden Nathan J | sell | 15,000 | $15.33 | $230K | n/a |
| 4 May 2026 | Sethuraman Natarajan | sell | 25,907 | $15.39 | $399K | n/a |
| 2 Apr 2026 | WENTWORTH KORY JAMES | sell | 2,500 | $12.95 | $32.4K | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought TRDA?
0 Congress buys by 0 members and 1 insider buy are on file. The tables on this page list every one.
Did buying TRDA after a disclosure beat the market?
Across 1 scored buy, Insiders averaged +13.3% against the S&P 500 (SPY) over the 90 days after disclosure, with 100% of them ahead of the index. That result is too few trades to tell. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.